Clevidipine for treating high blood pressure after a brain bleed
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a blood pressure medicine called clevidipine given through an IV to people with a brain bleed (intracerebral hemorrhage). The goal is to see if quickly lowering blood pressure helps prevent more bleeding and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 99 years old.
- Your stroke symptoms began within the last 12 hours.
- A CT scan shows a brain bleed larger than 5 mL (not just tiny spots).
- Your blood pressure on arrival was between 150 and 220 mmHg.
- You are not pregnant, breastfeeding, or had a baby in the last 30 days.
- You are not allergic to soybeans, eggs, or similar medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving tranexamic acid (a medicine that helps clots stay stable) along with intensive blood pressure lowering can reduce bleeding in the brain and improve recovery. It is for people who arrive at the hospital very quickly after a hemorrhagic stroke.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
This trial tests how managing high blood pressure during clot-dissolving treatment for acute ischemic stroke affects recovery. It is for patients who have high blood pressure at the start of treatment.
This trial tests a clot-busting drug called tenecteplase to see if it can safely treat a large brain bleed (intracerebral hemorrhage). It may help people who had a bleed within the last 24 hours and whose CT scans show the bleed has stopped growing.
This trial tests whether a combination of three blood pressure medicines can better control blood pressure after a brain bleed (intracerebral hemorrhage). It may help prevent another bleed or stroke.
This study tests whether the drug tranexamic acid can help stop bleeding in the brain when given early. It is for people with a spontaneous brain bleed who are awake and can be treated within 6 hours.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.